Junzo Hamanishi
Oncology — Kyoto Medical Center, Japan
Junzo Hamanishi
LeadR Profile
Oncology
Subspecialties: Gynecology - Obstetrics - Immunology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2002 - 2026
Number : 261
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Pharmacokinetic characterization of olaparib tablets in a hemodialysis patient with advanced ovarian cancer: a case report. research design, ovary, neoplasms, tablets, maintenance, ovarian neoplasms, therapeutics, plasma | Int Cancer Conf J | 2026 | 1 |
| AI-Based Analysis of Tumor-Infiltrating Lymphocytes and Homologous Recombination in Ovarian Cancer: JGOG3025-A1 Study. cells, telepathology, recombination, genetic, homologous recombination, lymphocytes, lymphocytes, tumor-infiltrating, ovary, neoplasms, deep learning, ovarian neoplasms, artificial intelligence | Cancer Sci | 2026 | 0 |
| Correction: Differentiating uterine adenosarcoma from endometrial polyps: MRI imaging features. polyps, diagnostic imaging, adenosarcoma | Abdom Radiol (NY) | 2026 | 0 |
| Mutational Signature-Based Biomarker for Phase II Trial of Olaparib Maintenance in Advanced High-Grade Ovarian Cancer. cicatrix, ovary, neoplasms, bevacizumab, biomarkers, maintenance, ovarian neoplasms, exome, mutation | Cancer Sci | 2026 | 0 |
| A novel CDK12 inhibitor induces homologous recombination deficiency to enhance PARP inhibitor efficacy in uterine serous carcinoma. genes, recombination, genetic, poly(adp-ribose) polymerase inhibitors, homologous recombination, neoplasms, therapeutics | Mol Cancer Ther | 2026 | 0 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map